Fondazione Gianni Benzi Onlus, as partner of the conect4children (c4c) network, is glad to share good news for the Kawasaki disease.
Kawasaki disease involves the inflammation of arteries, particularly the coronary arteries in the heart, sometimes causing irreversible heart damage, heart attacks or even death. To prevent heart damage, Kawasaki disease in children and young people must be recognised by clinicians early, and promptly treated with anti-inflammatory medicines.
c4c network has announced that the first site is now open to recruitment for the “Kawasaki Disease Coronary Artery Aneurysm Prevention trial (KD-CAAP)” study at Great Ormond Street Hospital NHS Foundation Trust (London, UK). This study will assess the effectiveness of adding steroids to standard treatment in children with Kawasaki Disease and aims to recruit 262 children as part of the study.
The KD-CAAP study is the first of the proof of viability studies, to begin recruitment. The other academic studies plan to begin recruitment later this year. These studies will exploit the infrastructure and resources of the c4c network, whose goal is to improve the European paediatric clinical trial infrastructure in order to facilitate the development of new, innovative and safer medicines for children in Europe.
This communication reflects the views of the c4c Consortium only and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein. H2020-JTI-IMI2-2016-10. Proposal: 77738.
Project Office/General Enquiries: Email us: email@example.com